Active Ingredient History

NOW
  • Now
Epoetin beta (rINN) is a synthetic, recombinant form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
1-165-erythropoietin (human clone lamdahepofl13 protein moiety), glycoform beta | bm 06.019 | epoch | epoetin beta | epoetin beta (genetical rcombination) | marogen | neorecormon | neorecormon 1000 | neorecormon 10000 | neorecormon 2000 | neorecormon 20000 | neorecormon 3000 | neorecormon 30000 | neorecormon 4000 | neorecormon 500 | neorecormon 5000 | neorecormon 6000 | recombinant 1-165-erythropoietin glycoform beta | recormon | recormon 1000 | recormon 10000 | recormon 2000 | recormon 5000 | recormon s 1000 | recormon s 10000 | recormon s 2000 | recormon s 5000

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue